Gastrointestinal Endoscopy
Volume 71, Issue 1 , Pages 176-179 , January 2010

EUS-guided in vivo microdialysis of the pancreas: a novel technique with potential diagnostic and therapeutic application

Received 11 February 2009 ,Accepted 29 May 2009.

References 

  1. Delgado JM, DeFeuds FU, Roth RH, et al. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther. 1972;198:9–21
  2. Müller M. Science, medicine, and the future: Microdialysis. BMJ. 2002;324:588–591
  3. Lee GJ, Park HJ, Park HK. Microdialysis applications in neuroscience. Neurol Res. 2008;30:661–668
  4. Zhou Q, Gallo JM. In vivo microdialysis for PK and PD studies of anticancer drugs. AAPS J. 2005;7:E659–E667
  5. Müller M, Mader RM, Steiner B, et al. 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res. 1997;57:2598–2601
  6. Mader RM, Schrolnberger C, Rizovski B, et al. Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer. Br J Cancer. 2003;88:782–787
  7. Joukhadar C, Klein N, Mader RM, et al. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Cancer. 2001;92:2190–2196
  8. Schmidt S, Banks R, Kumar V, et al. Clinical microdialysis in skin and soft tissues: an update. J Clin. Pharmacol. 2008;48:351–364
  9. Kitano M, Norlén P, Håkanson R. Gastric submucosal microdialysis: a method to study gastrin- and food-evoked mobilization of ECL cell histamine in conscious rats. Regul Pept. 2000;86:113–123
  10. Deeba S, Corcoles EP, Hanna BG, et al. Use of rapid sampling microdialysis for intraoperative monitoring of bowel ischemia. Dis Colon Rec. 2008;51:1408–1413
  11. Gan SI, Rajan E, Adler DG, et al. Role of EUS. Gastrointest Endosc. 2007;66:425–434
  12. Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:455–465
  13. Ueno H, Okusaka T, Ikeda M, et al. A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer. Oncology. 2005;69:421–427
  14. Nakamura K, Yamaguchi T, Ishihara T, et al. Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. Br J Cancer. 2006;94:1575–1579
  15. Tatsumi K, Fukushima M, Shirasaka T, et al. Inhibitory effects of pyrimidine, barbituric acid and pyrimidine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn J Cancer. 1987;78:748–755
  16. Takechi T, Fujioka A, Matsushima E, et al. Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyrimidine (CDHP) in human tumour cells. Eur J Cancer. 2002;38:1271–1277
  17. Shirasaka T, Shimamoto Y, Fukushima M, et al. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumour activity in rats. Cancer Res. 1993;53:4004–4009
  18. Marunaka T, Umeno Y. Gas chromatographic-mass fragmentographic determination of 5-fluorouracil as a metabolic of new 5-fluorouracil derivatives. Chem Pharm Bull. 1982;30:1868–1871
  19. Odagiri H, Ichihara S, Semura E, et al. Determination of 5-fluorouracil in plasma and liver after oral administration of 5′-deoxy-5-fluorouridine using gas chromatography-mass spectrometry. J Pharmacobiodyn. 1988;11:234–240
  20. Nakagawa A, Samols E, Stagner JI. Exocrine interstitial insulin and somatostatin in the perfused dog pancreas. Am J Physiol (Gastrointest Liver Physiol). 1993;264:G728–GG34
  21. Meriläinen S, Mäkelä J, Anttila V, et al. Acute edematous and necrotic pancreatitis in a porcine model. Scand J Gastroenterol. 2008;43:1259–1268

 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. The microdialysis probe was made for this study by Eicom Co. Ltd. according to our specifications, but there was no financial relationship. The microdialysis probe and the microinfusion pump are commercially available. This study was supported by grants from the Japan Society for Promotion of Science, the Japan Research Foundation for Clinical Pharmacology, and the Japanese Foundation for Research and Promotion of Endoscopy.

 If you would like to chat with an author of this article, you may contact Dr. Kitano at m-kitano@med.kindai.ac.jp.

PII: S0016-5107(09)02075-6

doi: 10.1016/j.gie.2009.05.040

Gastrointestinal Endoscopy
Volume 71, Issue 1 , Pages 176-179 , January 2010

Article Tools

* Image Usage & Resolution